Fig. 2From: Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metforminPlot of Mean (± standard error) Change from Baseline in Fasting Plasma Lactic Acid Concentration (mmol/L). Trt A, Remogliflozin Etabonate 500 mg + metformin; Trt B, Remogliflozin Etabonate 750 mg + metforminBack to article page